Akorn (AKRX) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free AKRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAkorn Reaches New 52-Week High (AKRX)thestreet.com - May 15 at 8:04 AMCarlin Consumer Health Names Scott Chapman Chief Executive Officer - Business Wirebusinesswire.com - October 20 at 9:52 AMVeterinary Eye Care Market Size to record USD 788.78 Million Growth at a CAGR of 4.65% by 2026, Evolving Opportunities with Bausch Health Co Inc. And Akorn Operating Co. - Technavio - PR Newswireprnewswire.com - October 10 at 8:00 PMA small fund wagered that Elon Musk would be forced to buy Twitter—and made a killing by betting against the crowd - Fortunefortune.com - October 9 at 7:20 PMDiuretic Drugs Market to Record a CAGR of 5.44%, Increasing Incidence of Hypertension Among People to Drive Growth - Technavio - Yahoo Financefinance.yahoo.com - September 29 at 9:20 PMMoody's downgrades Akorn to Caa2; revises outlook to stable from positive - Moody'smoodys.com - September 15 at 7:40 PMPrestige Consumer (PBH) Brands & E-commerce Strength Bode Well - Nasdaqnasdaq.com - September 2 at 6:27 PMThe Worldwide Inhalation & Nasal Sprays Generic Drugs Industry is Expected to Reach $11.2 Billion by 2027 - ResearchAndMarkets.com - Business Wirebusinesswire.com - August 29 at 9:20 AMShort-sellers, lawyers, and academics predict the odds Elon Musk will be forced to close on a $44 billion deal he hates - Fortunefortune.com - August 27 at 8:07 AMThe Worldwide Glaucoma Treatment Industry is Expected to Reach $9.1 Billion by 2027 - ResearchAndMarkets.com - Business Wirebusinesswire.com - August 26 at 12:05 PMConjunctivitis Market to Grow at a Healthy CAGR of 5.8% from 2022 to 2032 Owing to Growing Disease Prevalence Globally | Future Market Insights, Inc. - GlobeNewswireglobenewswire.com - August 26 at 12:05 PMWhistleblower Claims Rattle Twitter's Bid To Force Musk Deal - Law360law360.com - August 23 at 10:34 PMAkorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg - Bloombergbloomberg.com - August 17 at 5:14 AMAkorn Announces FDA-approved Generic Cetrorelix Acetate for Injection 0.25 mg - PR Newswireprnewswire.com - August 16 at 2:12 PMPterygium Drug Market Trends, Shares, Key Players, Regional Overview and Market Is Growing At CAGR Of 6.2% By 2029 - GlobeNewswireglobenewswire.com - August 11 at 6:17 AMDelaware Powerhouse: Paul Weiss - Law360law360.com - August 5 at 10:47 PMPrestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023 - StreetInsider.comstreetinsider.com - August 4 at 10:15 AMThe Global Animal Sedative Market is expected to grow by $ 190.96 mn during 2022-2026, accelerating at a CAGR of 5.85% during the forecast period - Yahoo Financefinance.yahoo.com - August 1 at 2:08 PMUM6P Ventures Invests in Akorn Technology to Reduce Global Food Waste - GlobeNewswireglobenewswire.com - July 26 at 10:50 AMBleeding Disorders Treatment Market to Receive Irresistible Growth of USD 11.65 Billion by 2029 with Size, Share Global Industry Trends, Top Players and Revenue Analysis - PR Newswireprnewswire.com - July 20 at 11:07 AMIllinois Cases To Watch In 2nd Half Of 2022 - Law360law360.com - July 14 at 10:32 PMThe fight between Musk and Twitter will come down to 3 words—and they rarely work - Fortunefortune.com - July 11 at 3:47 PMAnalysis: Twitter has legal edge in deal dispute with Musk - Reuters.comreuters.com - July 9 at 4:56 AMPrestige Consumer (PBH) Brand-Building Efforts Solid, Costs High - Nasdaqnasdaq.com - June 14 at 4:41 PMThe Global Anaplastic Thyroid Cancer Drugs Market is expected to grow by $ 230.53 mn during 2022-2026, accelerating at a CAGR of 5.44% during the forecast period - Yahoo Financefinance.yahoo.com - June 10 at 8:41 AMGlobal Eye Drop (Prescription v/s Over-the-Counter) Markets, Analysis, Competition, Forecast and Opportunities, 2017-2021 & 2022-2027 - ResearchAndMarkets.com - Business Wirebusinesswire.com - June 7 at 4:29 PMElon Musk's Twitter Deal Has Become A Multibillion-Dollar Game Of Chicken - Forbesforbes.com - June 7 at 6:24 AMGlobal Glaucoma Treatment Market Report (2022 to 2032) - Players Include Aerie Pharmaceuticals, Cipla, Abbvie and Akorn Operating Company - ResearchAndMarkets.com - Business Wirebusinesswire.com - May 30 at 7:59 AMGlobal Clindamycin Phosphate Injection Market to 2027 - Featuring Akorn, Baxter International and Pfizer Among Others - ResearchAndMarkets.com - Business Wirebusinesswire.com - May 17 at 5:13 PMGlobal Clindamycin Phosphate Injection Market to 2027 - Featuring Akorn, Baxter International and Pfizer Among Others - ResearchAndMarkets.com - Yahoo Financefinance.yahoo.com - May 17 at 7:13 AMElon Musk can't use Twitter bots to get out out of acquisition agreement - The Washington Postwashingtonpost.com - May 14 at 9:20 AMPrestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat - Yahoo Financefinance.yahoo.com - May 6 at 12:28 PMPrestige Consumer Healthcare Inc. Reports Record Results for Fiscal 2022 - GlobeNewswireglobenewswire.com - May 5 at 9:27 PMWhat's in Store for Prestige Consumer (PBH) in Q4 Earnings? - Nasdaqnasdaq.com - May 4 at 12:48 PMGlobal eye drop market was valued at USD13530 million in 2021 and is anticipated to grow with a CAGR of 6.46% during the forecast period to achieve a market value of USD19758 million by 2027 - Yahoo Financefinance.yahoo.com - May 4 at 7:48 AMGlobal Antispasmodics Drugs Market Research Report to 2027 - Increasing Patient Awareness Level and Improvement in Treatment Presents Opportunities - ResearchAndMarkets.com - Business Wirebusinesswire.com - April 23 at 8:19 PMGlobal Veterinary Eye Care Market - Growth, Trends, and Forecasts (2022 - 2027) - ResearchAndMarkets.com - Yahoo Financefinance.yahoo.com - April 20 at 1:01 AMBronchitis Treatment Market Size to Grow by USD 1.12 bn | Technavio - Yahoo Financefinance.yahoo.com - March 18 at 2:45 AMDry Eye Medication Global Market Report 2022 - Yahoo Financefinance.yahoo.com - March 16 at 10:08 AMPrestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce - Nasdaqnasdaq.com - March 14 at 12:46 PMWhy Is Model N (MODN) Down 6% Since Last Earnings Report? - Nasdaqnasdaq.com - March 10 at 2:11 PMAkorn Announces Completion of the Sale of its Branded Ophthalmic Products to Théa Pharma - PR Newswireprnewswire.com - March 9 at 12:56 PMModel N Announces First Quarter Fiscal Year 2022 Financial Results - Yahoo Financefinance.yahoo.com - February 9 at 12:22 AMPrestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results - StreetInsider.comstreetinsider.com - February 3 at 1:56 PMPrestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results - Yahoo Financefinance.yahoo.com - February 3 at 8:55 AMThéa to Acquire Branded Ophthalmic Products from Akorn, Expanding Théa's Presence into the U.S. Eye Care Industry - Business Wirebusinesswire.com - January 28 at 8:23 PMAkorn Announces Agreement to Sell its Branded Ophthalmic Products to Théa - PRNewswireprnewswire.com - January 28 at 3:23 PMWhole Earth Brands (FREE) Appoints Duane Portwood as New CFO - StreetInsider.comstreetinsider.com - January 10 at 11:31 AMIndia Active Pharmaceutical Ingredients Market to surpass US$ 34,968.7 Million by 2028, Says Coherent Market Insights (CMI) - Yahoo Financefinance.yahoo.com - December 24 at 2:51 PMInsights on the Pharma Ophthalmic Global Market to 2026 - Featuring Roche, Santen and Senju Among Others - Yahoo Finance UKuk.finance.yahoo.com - December 16 at 3:05 PM Get Akorn News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad)If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details AKRX Media Mentions By Week AKRX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKRX News Sentiment▼0.000.32▲Average Medical News Sentiment AKRX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKRX Articles This Week▼00▲AKRX Articles Average Week Get Akorn News Delivered to You Automatically Sign up to receive the latest news and ratings for AKRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: GeoVax Labs News Today Virpax Pharmaceuticals News Today Mustang Bio News Today Evoke Pharma News Today Revelation Biosciences News Today Phio Pharmaceuticals News Today Atreca News Today Hillstream BioPharma News Today Aridis Pharmaceuticals News Today Ensysce Biosciences News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKRX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersFed launches fourth dollar overhaulStansberry ResearchBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akorn, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
